#alector - Twitter Hashtag

6 months ago

ENCORP | Anti-drone και εξειδικευμένα στρατιωτικά οχήματα στο BATTLEFIELD ReDEFiNED 2026 #ENCORP #BATTLEFIELD_ReDEFiNED #ALECTOR #DroneEye https://t.co/CxMKbb15QU

0

11

4

303

DEFENCE ReDEFiNED

@Def_Redefined

7 months ago

Η ENCORP στο BATTLEFIELD ReDEFiNED 2026 | Anti-drone συστήματα και ειδικά οχήματα θα παρουσιάσει η κυπριακή εταιρεία #ENCORP #BATTLEFIELD_ReDEFiNED #ALECTOR https://t.co/qTu4jpYM6Q

Def_Redefined's tweet photo. Η ENCORP στο BATTLEFIELD ReDEFiNED 2026 | Anti-drone συστήματα και ειδικά οχήματα θα παρουσιάσει η κυπριακή εταιρεία #ENCORP #BATTLEFIELD_ReDEFiNED #ALECTOR
https://t.co/qTu4jpYM6Q https://t.co/CsByDbmr59

0

13

3

1

240

αἰθεροβάμων @aethrvmn

over 1 year ago

As a reminder, an #alector is a simple RL agent, in this case PPO (although DDQN/SAC are on their way), equipped with a pretrained encoder (bert-base), so that the Actor and the Critic are fed the vector representation of the state description. Extremely simple, but novel(?)

1

0

36

Hottest Stocks Now @HottestStockNow

over 2 years ago

Alector and GSK: FDA Grants Latozinemab Breakthrough Therapy Designation for Frontotemporal Dementia Due to a Progranulin Gene Mutation (FTD-GRN) $ALEC, $GSK, #Alector, #GSK https://t.co/39fH7NE8pR

0

5

0

188

Fenghua Hu @fenghua_hu

about 3 years ago

Our study to test the efficacy of #AAV-GRN in rescuing motor deficits and #ALS #FTD pathology in #Tmem106b #Grn double KO mice just got published! Great collaboration with #Alector and #Postdoc Tuancheng Feng has done an amazing job! https://t.co/sorerHs3Ms

1

41

4

4K

Carterra @carterra_bio

over 4 years ago

Join industry-leading scientists from #LJI, #Symphogen, #Alector, #UCB, #GSK and #Carterra as they discuss the latest advancements in antibody discovery. Attend the free one-day symposium in Munich and network with peers. Register below. https://t.co/ipTyakGNjy

carterra_bio's tweet photo. Join industry-leading scientists from #LJI, #Symphogen, #Alector, #UCB, #GSK and #Carterra as they discuss the latest advancements in antibody discovery. Attend the free one-day symposium in Munich and network with peers. Register below.

https://t.co/ipTyakGNjy https://t.co/65iENRC7jc

0

2

0

Carterra @carterra_bio

over 4 years ago

Join our Keynote Speaker, Dr. Kate Hastie from the La Jolla Institute for Immunology, as she kicks off a science-filled day at our free upcoming symposium, Unlocking High-throughput Biology. https://t.co/ipTyakpcs0 #LJI #Symphogen #Alector #UCB #GSK #antibodydiscovery #biologics

carterra_bio's tweet photo. Join our Keynote Speaker, Dr. Kate Hastie from the La Jolla Institute for Immunology, as she kicks off a science-filled day at our free upcoming symposium, Unlocking High-throughput Biology. https://t.co/ipTyakpcs0

#LJI #Symphogen #Alector #UCB #GSK #antibodydiscovery #biologics https://t.co/WOOC9Zr2JY

0

2

0

Evaluate Japan @EvaluateJP

about 5 years ago

GSK社は、#Alector 社に7億ドルの契約一時金を支払い、複数の神経変性疾患との遺伝的関連が指摘されている #progranulin レベルを上昇させる2つの抗体薬 #AL001 と #AL101 の共同開発権を手に入れた。 https://t.co/S5I9TrB9fU #エバリュエート

EvaluateJP's tweet photo. GSK社は、#Alector 社に7億ドルの契約一時金を支払い、複数の神経変性疾患との遺伝的関連が指摘されている #progranulin レベルを上昇させる2つの抗体薬 #AL001 と #AL101 の共同開発権を手に入れた。
https://t.co/S5I9TrB9fU
#エバリュエート https://t.co/VinMkbPbg4

0

5

2

0

Roxane Nojac @roxaneno

about 5 years ago

C'est déjà l'heure de Pump/Dump ?! 🥳😃 Avec #Alector, #SydneyAirport, #VirginGalactic, #Kraton, #Virbac, #Alstom, #Teamviewer, #Baidu, #BioNTech, et #BMW ! @Zonebourse https://t.co/BuzFbiGq5w

0

12

5

0

Agustin Ibañez

@AgustinMIbanez

over 5 years ago

Dementia Research Latin America (#ReDLat) is pleased to announce a new research grant funded by #Alector that will explore genetic factors in families with #FTD across the region https://t.co/G95rzKjMcg @atlanticfellows @BrainlatUAI @LACCD9 @CNCUdeSA @GBHI_Fellows @UCSFmac

0

23

6

0

Tickeron

@Tickeron

over 5 years ago

$ALEC's in Uptrend: Moving Average Convergence Divergence (MACD) Histogram just turned positive. View odds for this and other indicators: https://t.co/h9CZ8q2esb #Alector #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today

Tickeron's tweet photo. $ALEC's in Uptrend: Moving Average Convergence Divergence (MACD) Histogram just turned positive. View odds for this and other indicators: https://t.co/h9CZ8q2esb #Alector #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/XGh13PHjf1

0

1

0

ALLFTD @allftd

about 6 years ago

Exciting talk by #Alector, reporting Phase 2 data for AL001. Watch it on-demand if you haven't seen it yet! OD-Drug Development: AL001 resorts CSF PGRN levels & normalizes disease-associated biomarkers in individuals with FTD due to heterozygous mutations in the GRN gene. #endFTD

0

4

2

0

Bluefield Project @BluefieldProj

about 6 years ago

4/ In addition, multiple secondary clinical endpoints plus imaging and fluid biomarkers will be assessed. This is the first Phase 3 trial ever conducted in FTD-GRN. Congratulations to #Alector on this huge milestone!

0

1

0

Bluefield Project @BluefieldProj

about 6 years ago

1/ Today #Alector announced that it has dosed the first participant in its pivotal Phase 3 clinical trial, #INFRONT-3, to evaluate the monoclonal anti-sortilin antibody AL001 in individuals with or at risk for FTD caused by mutations in #progranulin. https://t.co/8UerFFyAyV

1

6

3

0

BRAINCURES LTD @BraincuresLTD

about 6 years ago

15 of Top 59 #BiotechStartups @Roivant @synergyherpes @DicernaPharma @insitro @RecursionPharma @Rev_Medicine @benevolent_ai #Alector @ArrowheadPharma #ideayabio @NimbusTx #tarisbiomedical @exscientialtd @Aslanpharma @StealthBT have raised $100 million #IoT https://t.co/74DzFmPPrR

BraincuresLTD's tweet photo. 15 of Top 59 #BiotechStartups
@Roivant @synergyherpes @DicernaPharma @insitro @RecursionPharma @Rev_Medicine @benevolent_ai #Alector @ArrowheadPharma #ideayabio @NimbusTx #tarisbiomedical @exscientialtd @Aslanpharma @StealthBT have raised $100 million
#IoT
https://t.co/74DzFmPPrR https://t.co/nhTkMdmhtP

1

2

10

0

Marc Suárez-Calvet 🧠🧪 🩺🌈 @M_SuarezCalvet

over 6 years ago

Importantly, #Alector AL002c anti-human #TREM2 antibody: -Is safe in a phase I clinical trial -CSF #sTREM2 as a target engagement biomarker? Congrats Shoutang Wang, @meerkmustafa , Tina Schwabe, Marco Colonna and colleagues! 👌

0

2

1

0

Marc Suárez-Calvet 🧠🧪 🩺🌈 @M_SuarezCalvet

over 6 years ago

In @JExpMed , #Alector AL002c anti-human #TREM2 antibody: -Activates TREM2 -Induces proliferation of microglia -Increases transitioning microglia -Decreases filamentous amyloid plaques and neurite dystrophy https://t.co/1kdoIMH9Js

1

13

6

0